[1]
S. Berik Safçi, Özlem Erçen Diken, S. Kara, and T. Serintürk, “The significance of SIRI and SII scores in predicting the effect of omalizumab treatment in patients with severe allergic asthma”, Allergol Immunopathol, vol. 53, no. 4, pp. 1–6, Jul. 2025, doi: 10.15586/aei.v53i4.1325.